Mineral metabolism disease
MONDO:0000226Also known as: disease of mineral metabolism, disorder of mineral metabolism
137 clinical trials for this condition and its sub-types, 2 tagged with Mineral metabolism disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Mineral metabolism disease
-
Calcium metabolic disease 5 trials · 62 incl. sub-types
4 sub-types
- Calcinosis 30 trials · 47 incl. sub-types Sub-types →
- Autosomal dominant hypocalcemia 9 trials · 10 incl. sub-types Sub-types →
- Hypercalcemia disease 4 trials · 7 incl. sub-types Sub-types →
- Calcium-alkali syndrome 0 trials
-
Phosphorus metabolism disease 1 trial · 33 incl. sub-types
2 sub-types
- Hyperphosphatemia 22 trials
- Hypophosphatemia 12 trials
-
Iron metabolism disease 2 trials · 22 incl. sub-types
2 sub-types
- Hemosiderosis 2 trials · 12 incl. sub-types Sub-types →
- Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types Sub-types →
-
Sulfur metabolism disease 0 trials · 14 incl. sub-types
4 sub-types
- Inborn disorder of methionine cycle and sulfur amino acid metabolism 0 trials · 11 incl. sub-types Sub-types →
- Biotin metabolic disease 0 trials · 3 incl. sub-types Sub-types →
- Inherited glutathione metabolism disease 0 trials · 1 incl. sub-types Sub-types →
- Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types Sub-types →
-
Potassium deficiency disease 4 trials · 5 incl. sub-types
1 sub-type
-
Diastrophic dysplasia 2 trials
-
Achondrogenesis type IB 0 trials
-
Acquired mineral metabolism disease 0 trials
-
Atelosteogenesis type II 0 trials
-
Multiple epiphyseal dysplasia type 4 0 trials
Most studied deeper sub-types
-
Experimental drug targets dangerous calcium spike in cancer
Disease control Stopped earlyResearchers are testing an experimental drug called JMT103 in adults with cancer whose blood calcium levels are dangerously high and who have not responded to standard intravenous bisphosphonate treatment. Participants receive JMT103 as an injection under the skin every four week…
Phase 1/2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Slower magnesium drip may help sickest patients hold onto the mineral
Disease control Stopped earlyCritically ill patients often have low magnesium, which can lead to heart rhythm problems and other complications. When magnesium is given through an IV, the body keeps only about half of it. Researchers are testing whether giving the same dose over 8 hours instead of 4 hours hel…
Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC